Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…nfants, most were breastfed on natalizumab (n=125), followed by ocrelizumab (n=34), rituximab (n=11) and ofatumumab (n=10); three had multi…
…urred in 22.5% and 20.5% of patients, respectively. Exposure to rituximab was more likely to abandon therapy (χ²=4.8, p=0.03). Patient re…
…erim dexamethasone provided relief. Intensive chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine and methotrexate/if…
…, nocturnal non-invasive ventilation and immunosuppression with infliximab. Subsequent escalation of management included endobronchial ste…
…y confirmed bilateral pulmonary emboli and she was treated with apixaban. After discontinuing anticoagulation prematurely, she re-presen…
…w disease activity state (46.42%) and tapering glucocorticoids. Cyclophosphamide use was associated with greater clinical improvement (r=0.284; …
…inhibitors (4), tumour necrosis factor (TNF) inhibitors (1) and tocilizumab (1). Pooled analysis showed no significant overall change in FV…
… brain biopsy confirmed PML. Notably, she had been treated with mycophenolate mofetil and low-dose prednisolone, without rituximab. Her symptoms impr…
…ed that RDI is a critical determinant of outcome. Higher RDI of doxorubicin (HR 0.75−0.82) and cyclophosphamide (HR 0.97) was significantly…
…ease with highly variable manifestations. New therapies such as belimumab appear to reduce cumulative organ damage and disease flares, im…
…sis. The patient was treated with polatuzumab, bendamustine and rituximab, which was well tolerated. Renal function gradually improved, l…
…fections, most notably sepsis and influenza, when compared with belimumab, and these differences became more evident with longer exposure…